Ma, J., Yue, S., Liu, Y., Gong, L., He, P., Yang, Y., . . . Xu, L. (2025). Fucoxanthin ameliorates ulcerative colitis by maintaining the epithelial barrier via blocking JAK2/STAT3 signaling pathway. Toxicology and applied pharmacology.
Chicago Style (17th ed.) CitationMa, Jingjing, et al. Fucoxanthin Ameliorates Ulcerative Colitis by Maintaining the Epithelial Barrier via Blocking JAK2/STAT3 Signaling Pathway. Toxicology and applied pharmacology, 2025.
MLA (9th ed.) CitationMa, Jingjing, et al. Fucoxanthin Ameliorates Ulcerative Colitis by Maintaining the Epithelial Barrier via Blocking JAK2/STAT3 Signaling Pathway. Toxicology and applied pharmacology, 2025.
Warning: These citations may not always be 100% accurate.